IPL – 1H21 Result

Incitec Pivot is now under Algo Engine buy conditions.

The company reported 1H21 Sales of $1.72m with underlying EBITDA of $286m. The EBIT miss was primarily driven by Fertilizers and Dyno Americas, with Dyno APAC largely in-line.

Our Option Lab AI technology suggests looking at the following call.

Qube Holdings – Algo Buy

Qube Holdings is under Algo Engine buy conditions, with price support at $2.90. Consider a stop-loss on a break below the support.

In 2021, container port freight volumes are up on average 10 to 20% per month compared to last year.

25/5 Since writing the above post, QUB has found steady buying interest above the $2.90 support and the momentum indicators continue to trend higher.

A number of institutions have upgraded their price targets into the $3.40 to $3.60 range.

Cure ETF – Buy

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

Altium – Buy

Altium is under Algo Engine buy conditions. The share price is oversold and likely to rally from the current level.

A more conservative entry strategy will be to wait for the stochastic to turn higher or the price action to cross up through the 10-day average.

25/5 Since writing the above post in mid-May, ALU has rallied 20%. We anticipate a pick-up in earnings for the 6 month period ending June 30 and will be looking for confirmation that 2020 was an anomaly in the company’s growth trajectory.

Buy ALU with stops below $24.00

Qube Holdings – Algo Buy

Qube Holdings is under Algo Engine buy conditions, with price support at $2.90. Consider a stop-loss on a break below the support.

In 2021, container port freight volumes are up on average 10 to 20% per month compared to last year.

25/5 Since writing the above post, QUB has found steady buying interest above the $2.90 support and the momentum indicators continue to trend higher.

A number of institutions have upgraded their price targets into the $3.40 to $3.60 range.